MX2009012014A - Uso de ivabradina como agente de diagnostico en el metodo de angiografia coronaria mediante tomografia computarizada multicorte. - Google Patents

Uso de ivabradina como agente de diagnostico en el metodo de angiografia coronaria mediante tomografia computarizada multicorte.

Info

Publication number
MX2009012014A
MX2009012014A MX2009012014A MX2009012014A MX2009012014A MX 2009012014 A MX2009012014 A MX 2009012014A MX 2009012014 A MX2009012014 A MX 2009012014A MX 2009012014 A MX2009012014 A MX 2009012014A MX 2009012014 A MX2009012014 A MX 2009012014A
Authority
MX
Mexico
Prior art keywords
ivabradine
computed tomography
diagnostic agent
coronary angiography
angiography method
Prior art date
Application number
MX2009012014A
Other languages
English (en)
Inventor
Guy Lerebours-Pigeonniere
Ariane Dubost-Brama
Carmen Fleurinck
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40677692&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009012014(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of MX2009012014A publication Critical patent/MX2009012014A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Uso de ivabradina ó 3-{3-[{[(7S)-3,4-dimetoxibiciclo[4.2.0]octa-1, 3,5-trien-7-il]-metil}(metit)-amino]-propil}-7,8-dimetoxi-1,3,4,5 -tetrahidro-2H-3-benzazepin-2-ona, de sus sales de adición a un ácido farmacéuticamente aceptable y de sus hidratos, como agente de diagnóstico en el método de angiografía coronaria mediante tomografía computarizada multicorte.
MX2009012014A 2008-11-07 2009-11-06 Uso de ivabradina como agente de diagnostico en el metodo de angiografia coronaria mediante tomografia computarizada multicorte. MX2009012014A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806225A FR2938194B1 (fr) 2008-11-07 2008-11-07 Utilisation de l'ivabradine comme agent de diagnostic dans la methode d'angiographie coronaire par tomodensitometrie multicoupe

Publications (1)

Publication Number Publication Date
MX2009012014A true MX2009012014A (es) 2010-05-27

Family

ID=40677692

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009012014A MX2009012014A (es) 2008-11-07 2009-11-06 Uso de ivabradina como agente de diagnostico en el metodo de angiografia coronaria mediante tomografia computarizada multicorte.

Country Status (44)

Country Link
US (2) US20100119459A1 (es)
EP (1) EP2184065B1 (es)
JP (3) JP2010111673A (es)
KR (1) KR101168484B1 (es)
CN (1) CN101732734A (es)
AP (1) AP2635A (es)
AR (1) AR074294A1 (es)
AT (1) ATE516806T1 (es)
AU (1) AU2009235984B2 (es)
BR (1) BRPI0904376A2 (es)
CA (1) CA2685303C (es)
CL (1) CL2009002032A1 (es)
CO (1) CO6230160A1 (es)
CR (1) CR11094A (es)
CY (1) CY1112037T1 (es)
DK (1) DK2184065T3 (es)
EA (1) EA017641B1 (es)
EC (1) ECSP099715A (es)
ES (1) ES2370145T3 (es)
FR (1) FR2938194B1 (es)
GE (1) GEP20135729B (es)
GT (1) GT200900288A (es)
HR (1) HRP20110684T1 (es)
IL (1) IL201815A (es)
JO (1) JO2838B1 (es)
MA (1) MA31418B1 (es)
ME (1) ME00953B (es)
MX (1) MX2009012014A (es)
MY (1) MY145991A (es)
NI (1) NI200900195A (es)
NZ (1) NZ580984A (es)
PA (1) PA8847801A1 (es)
PE (1) PE20100744A1 (es)
PL (1) PL2184065T3 (es)
RS (1) RS51948B (es)
SA (1) SA109300653B1 (es)
SG (1) SG161186A1 (es)
SI (1) SI2184065T1 (es)
SV (1) SV2009003401A (es)
TW (1) TWI426923B (es)
UA (1) UA101612C2 (es)
UY (1) UY32202A (es)
WO (1) WO2010052394A1 (es)
ZA (1) ZA200907753B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011157721A2 (en) 2010-06-14 2011-12-22 Ratiopharm Gmbh Ivabradine-containing pharmaceutical composition
CN106580873A (zh) * 2016-11-08 2017-04-26 北京万全德众医药生物技术有限公司 伊伐布雷定或其可药用盐口服溶液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
WO2005014042A1 (ja) 2003-08-08 2005-02-17 Ono Pharmaceutical Co., Ltd. 短時間型β遮断薬を有効成分とする心拍数減少剤
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
FR2911279B1 (fr) * 2007-01-11 2009-03-06 Servier Lab Utilisation de l'ivabradine pour l'obtention de medicaments destines au traitement de la dysfonction endotheliale

Also Published As

Publication number Publication date
ME00953B (me) 2012-06-20
SI2184065T1 (sl) 2011-10-28
GEP20135729B (en) 2013-01-25
SA109300653B1 (ar) 2013-05-18
UY32202A (es) 2010-06-30
AR074294A1 (es) 2011-01-05
PA8847801A1 (es) 2010-06-28
CY1112037T1 (el) 2015-11-04
PE20100744A1 (es) 2010-10-30
KR101168484B1 (ko) 2012-07-26
CN101732734A (zh) 2010-06-16
IL201815A0 (en) 2010-06-30
JP2013049699A (ja) 2013-03-14
CO6230160A1 (es) 2010-12-20
EP2184065B1 (fr) 2011-07-20
AP2635A (en) 2013-04-05
MA31418B1 (fr) 2010-06-01
MY145991A (en) 2012-06-08
RS51948B (sr) 2012-02-29
ATE516806T1 (de) 2011-08-15
CL2009002032A1 (es) 2010-09-10
GT200900288A (es) 2012-01-31
CA2685303C (fr) 2012-04-17
AU2009235984A1 (en) 2010-05-27
JP2016040304A (ja) 2016-03-24
FR2938194B1 (fr) 2012-08-31
US20160361444A1 (en) 2016-12-15
BRPI0904376A2 (pt) 2011-09-06
AU2009235984B2 (en) 2011-05-12
ECSP099715A (es) 2010-06-29
EA017641B1 (ru) 2013-02-28
JO2838B1 (en) 2014-09-15
JP6029935B2 (ja) 2016-11-24
TWI426923B (zh) 2014-02-21
NZ580984A (en) 2010-12-24
SV2009003401A (es) 2010-02-17
TW201021834A (en) 2010-06-16
CA2685303A1 (fr) 2010-05-07
PL2184065T3 (pl) 2011-12-30
CR11094A (es) 2009-12-02
EP2184065A1 (fr) 2010-05-12
US20100119459A1 (en) 2010-05-13
EA200901369A1 (ru) 2011-06-30
ES2370145T3 (es) 2011-12-13
IL201815A (en) 2013-08-29
JP2010111673A (ja) 2010-05-20
ZA200907753B (en) 2010-07-28
AP2009005035A0 (en) 2009-12-31
DK2184065T3 (da) 2011-10-24
HRP20110684T1 (hr) 2011-10-31
SG161186A1 (en) 2010-05-27
WO2010052394A1 (fr) 2010-05-14
KR20100051549A (ko) 2010-05-17
NI200900195A (es) 2011-08-03
FR2938194A1 (fr) 2010-05-14
UA101612C2 (uk) 2013-04-25

Similar Documents

Publication Publication Date Title
MX365986B (es) Derivativos de piperidina fusionados con espiro para usarse como inhibidores del canal de potasio medular externo renal.
NZ590923A (en) Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
AR080483A1 (es) Metodo para estabilizar dispersiones acuosas de compuestas bioactivos en agua
BRPI1010261A2 (pt) agente e método de formação de imagem in vivo, composto precursos, métodos para a preparação de um composto precursor e do agente de formação de imagem in vivo, e para diagnostico de uma condição, kit, cassete,e , composição radiofarmaceutica.
WO2012001065A3 (en) Use of alpha-adrenergic receptor agonist for preventing or treating skin tumor
GB201105050D0 (en) Pharmaceutical agent
BR112014002940A2 (pt) uso e composição agroquímica de dibutilamidas de ácido carboxílico
AU2010332841A8 (en) Prostate specific membrane antigen inhibitors
WO2012106524A3 (en) Diagnosis and treatment of the prodromal schizophrenic state
CL2007002637A1 (es) Compuestos derivados de acido 2-fenoxinicotinico; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de dislipidemias, arteriosclerosis e insuficiencia cardiaca.
EP2666122A4 (en) Optimized implementation of back projection for computed tomography (ct)
PH12013501017A1 (en) Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system
BR112012023063A2 (pt) processo para a preparação de uma composição para raio x, e, composição de diagnóstico para raio x
AP2635A (en) Use of ivabradine as diagnostic agent in the method of coronary angiography by multislice computed tompgraphy.
PH12015501643A1 (en) Methods of use of phenoxypropylamine compounds to treat depression
신영석 Direction to go for medical aid
MX2011012602A (es) Proceso para la preparacion de un agente de yodatacion.
PL394539A1 (pl) Sposób wytwarzania suplementu diety zawierajacego chelat lub chelaty oraz aktywne zwiazki o dzialaniu fizjologicznym z powloka dojelitowa rdzenia jego tabletki oraz suplement diety wytwarzany tym sposobem
WO2009150139A3 (en) Indolyl-pyridazinyl-diazabicyclononane derivatives in labelled and unlabelled form and their use in diagnostic methods
GB201110767D0 (en) Infection imaging
Leber The new Benchmark in Computed Tomography-Dual Source CT
安原洋 Holding for the 86th Annual Meeting of the JSMI
Shimizu Technologies for Organ Engineering
Hirabayashi The Diagnosis of Airway and Esophageal Foreign Body

Legal Events

Date Code Title Description
FG Grant or registration